MedPlus Health Services Limited, Incorporated in 2006, headquartered in Hyderabad, which is one of the largest Indian Pharmaceutical manufacturers/ retailer in the country is aiming to raise Rs. 1,398.30 Crore from Medplus Health Initial public offering.
MedPlus Health IPO comprises worth Rs. 600 Crore fresh issue and the offer for sale for Equity Shares which worths around Rs. 798.30 Crore.
Table of Contents
Medplus Health IPO 2021 All Details
|Medplus IPO Opening Date||Dec 13, 2021|
|Medplus IPO Closing Date||Dec 15, 2021|
|Issue Type||Book Built Issue IPO|
|Face Value||₹2 per equity share|
|IPO Price||₹780 to ₹796 per equity share|
|Market Lot||18 Shares|
|Min Order Quantity||18 Shares|
|Listing At||BSE, NSE|
|Issue Size||Worth Rs. 1,398.30 Crore|
|Fresh Issue||Worth Rs. 600.00 Crore|
|Offer for Sale||Worth Rs. 798.30 Crore|
Medplus Health IPO 2021 Dates
|Medplus IPO Open Date||Dec 13, 2021|
|Medplus IPO Close Date||Dec 15, 2021|
|Allotment Date||Dec 20, 2021|
|Initiation of Refunds||Dec 21, 2021|
|Credit of Shares to Demat||Dec 22, 2021|
|Medplus IPO Listing Date||Dec 23, 2021|
Medplus Health IPO 2021 Fresh Issue vs OFS
The Metro Brands comprises fresh issue as well as offer for sale which is in total aggregating upto Rs. 1,398.30 Crore.
- Fresh Issuance – Worth Rs. 600 Crore
- Offer for sale (Promotor’s) – Worth Rs. 798.30 Crore
Medplus Health IPO 2021 Lot Size
Medplus Health IPO 2021 Allotment
The IPO allotment of Medplus Health is scheduled in the upcoming week on December 20, 2021 and the allotted shares will be credit into demat accounts on/by December 22, 2021.
Medplus Health IPO 2021 GMP Today
The grey market premium of Medplus Health IPO 2021 is around Rs. 285-305 on December 12, 2021. Medplus Health IPO GMP in percentage is around 36% – 38%.
- Medplus IPO GMP : Rs. 285-305 ( Dec 12)
Medplus Health IPO 2021 Issue Objectives
The Medplus Health Services Limited, aims to utilize the net proceed towards the following listed purposes.
- Funding working capital requirements of their Material Subsidiary, Optival.
- General corporate purposes.
- The proceeds of the Offer for Sale will be received by the Selling Shareholders.
Medplus Health Company Financials
|Rs. in Millions||30-Sep-21||31-Mar-21||31-Mar-20||31-Mar-19|
|Profit After Tax||663.67||631.11||17.94||119.22|
Medplus Health Company Promoters
The promotors of Medplus Health Services Limited include Gangadi Madhukar Reddy, Agilemed Investments Private Limited and Lone Furrow Investments Private Limited.
Medplus Health Company Overview
Medplus Health Services Limited, which is one of the largest Pharmaceutical manufacturers/ retailer in the country, was founded in 2006 by Gangadi Madhukar Reddy (Managing Director and Chief Executive Officer) with the vision to set up a trusted pharmacy retail brand that offers genuine medicines and delivers better value to the customer by reducing inefficiencies in the supply chain using technology.
Medplus Health Services Limited operates 2,165 stores in 242 cities distributed across Tamil Nadu, Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal and Maharashtra as of June 30, 2021. The Company has a total of 14,762 permanent full-time in-house employees working in a range of business activities.
Medplus Health Services Limited shareholders include marquee investors, including Lavender Rose, belonging to the Warburg Pincus group, and affiliates of Premji Invest.
Their operations include the manufacturing and contract manufacturing of private label pharmaceutical, wellness and FMCG products, wholesale and retail sale, import, distribution, and pathology diagnostic laboratory testing.
Their ‘click and pick’ service allows customers to place orders directly online for collection at their preferred store at a convenient time. Their customers also have the option to return any items purchased through our online channel at their preferred stores, subject to the standard terms and conditions. Through their ‘door-to-door’ delivery service, in the cities of Hyderabad and Bangalore, their customers can place orders over the telephone, through our website or their mobile application.